Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A meta-regression analysis of treatment effect modifiers in trials with flexible-dose oral sildenafil for erectile dysfunction in broad-spectrum populations

International Journal of Impotence Research volume 18, pages 559–565 (2006)Cite this article

Abstract

Several trials and reviews provide evidence for the efficacy of phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction (ED). However, little is known about the impact of treatment effect modifiers other than concomitant diseases. Our objective was to identify patient and trial characteristics as well as methodological and publication-related issues that are associated with the treatment effect measured in flexible-dose randomized controlled trials of oral sildenafil for ED. The MEDLINE and the Cochrane Central databases were searched for efficacy trials of sildenafil. Thirteen trials fulfilled all inclusion criteria. A series of meta-regression and graphical analyses were performed to test the impact of possible effect modifiers. Treatment effect was influenced by mean baseline disease severity and mean duration of the disease. These associations were at least partly mediated by placebo response. Trial duration, age of patients and etiology of ED in patients did not have any significant influence on the treatment effect. The year of publication of primary trials was also related to trial findings. Our analysis adds important data to enable the control of confounding variables in future trials and meta-analyses. It might also help the individual to assess the unbiased efficacy and true innovative potential of available and forthcoming pharmacological agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M . The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004; 20: 607–617.

    Article  Google Scholar 

  2. Nicolosi A, Glasser DB, Moreira ED, Villa M, Erectile Dysfunction Epidemiology Cross National Study Group. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003; 15: 253–257.

    Article  CAS  Google Scholar 

  3. Kubin M, Wagner G, Fugl-Meyer AR . Epidemiology of erectile dysfunction. Int J Impot Res 2003; 15: 63–71.

    Article  CAS  Google Scholar 

  4. Brock G . Oral agents: first-line therapy for erectile dysfunction. Eur Urol Suppl 2002; 1: 12–18.

    Article  CAS  Google Scholar 

  5. Gresser U, Gleiter CH . Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil – review of the literature. Eur J Med Res 2002; 7: 435–446.

    CAS  PubMed  Google Scholar 

  6. Carson CC, Rajfer J, Eardley I, Carrier S, Denne JS, Walker DJ et al. The efficacy and safety of tadalafil: an update. BJU Int 2004; 93: 1276–1281.

    Article  CAS  Google Scholar 

  7. Hellstrom WJ . Vardenafil: a new approach to the treatment of erectile dysfunction. Curr Urol Rep 2003; 4: 479–487.

    Article  Google Scholar 

  8. Carson CC, Burnett AL, Levine LA, Nehra A . The efficacy of sildenafil citrate (viagra) in clinical populations: an update. Urology 2002; 60 (Suppl 2B): 12–27.

    Article  Google Scholar 

  9. Berner MM, Kriston L, Harms A . Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad spectrum populations. Int J Impot Res 2006 (in print).

  10. Burls A, Gold L, Clark W . Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract 2001; 51: 1004–1012.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ . Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002; 162: 1349–1360.

    Article  CAS  Google Scholar 

  12. Markou S, Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G . Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports. Int J Impot Res 2004; 16: 470–478.

    Article  CAS  Google Scholar 

  13. Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR et al. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy. BJU Int 2005; 96: 1323–1332.

    Article  CAS  Google Scholar 

  14. Rosen RC, Riley A, Wagner G . The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  Google Scholar 

  15. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH . Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346–351.

    Article  CAS  Google Scholar 

  16. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1–12.

    Article  CAS  Google Scholar 

  17. Deeks JJ, Higgins JPT, Altman DG . Analysing and presenting results. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 8. The Cochrane Library, Issue 3, John Wiley & Sons, Ltd: Chichester, UK 2005.

    Google Scholar 

  18. Sharp SJ, Thompson SG, Altman DG . The relation between treatment benefit and underlying risk in meta-analysis. BMJ 1996; 313: 735–738.

    Article  CAS  Google Scholar 

  19. Sterne JAC, Egger M, Smith GD . Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101–105.

    Article  CAS  Google Scholar 

  20. Lipsey MW, Wilson DB . Practical Meta-Analysis, Applied Social Research Methods Series, Vol. 49. Sage Publications: London, 2000.

    Google Scholar 

  21. Thompson SG, Sharp SJ . Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18: 2693–2708.

    Article  CAS  Google Scholar 

  22. Wilson DB . SPSS, Stata, and SAS macros for performing meta-analytic analyses. http://mason.gmu.edu/~dwilsonb/ma.html. last uptated: 15-1-2002. accessed: 10-11-2003.

  23. Becher E, Tejada NA, Gomez R, Decia R, Southern Latin America Sildenafil Study Group. Sildenafil citrate (Viagra) in the treatment of men with erectile dysfunction in southern Latin America: a double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation study. Int J Impot Res 2002; 14 (Suppl 2): 33–41.

    Article  Google Scholar 

  24. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC . Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function. Urology 2000; 56: 477–481.

    Article  CAS  Google Scholar 

  25. Chen KK, Hsieh JT, Huang ST, Jiaan DB, Lin JS, Wang CJ et al. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res 2001; 13: 221–229.

    Article  CAS  Google Scholar 

  26. Choi HK, Ahn TY, Kim JJ, Kim SC, Paick JS, Suh JK et al. A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea. Int J Impot Res 2003; 15: 80–86.

    Article  CAS  Google Scholar 

  27. Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC . Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 1999; 53: 800–805.

    Article  CAS  Google Scholar 

  28. Glina S, Bertero E, Claro J, Damiao R, Faria G, Fregonesi A et al. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men. Int J Impot Res 2002; 14 (Suppl 2): S27–S32.

    Article  Google Scholar 

  29. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. New Engl J Med 1998; 338: 1397–1404.

    Article  CAS  Google Scholar 

  30. Gomez F, Davila H, Costa A, Acuna A, Wadskier LA, Plua P et al. Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study. Int J Impot Res 2002; 14 (Suppl 2): S42–S47.

    Article  Google Scholar 

  31. Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A, for the Thai investigators in ASSESS-2 Study Group. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study. J Med Assoc Thai 2003; 86: 195–205.

    PubMed  Google Scholar 

  32. Levinson IP, Khalaf IM, Shaeer KZ, Smart DO . Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa. Int J Impot Res 2003; 15 (Suppl 1): S25–S29.

    Article  CAS  Google Scholar 

  33. Meuleman E, Cuzin B, Opsomer RJ, Hartmann U, Bailey MJ, Maytom MC et al. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. BJU Int 2001; 87: 75–81.

    Article  CAS  Google Scholar 

  34. Tan HM, Moh CL, Mendoza JB, Gana T, Albano GJ, de la CR et al. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. Urology 2000; 56: 635–640.

    Article  CAS  Google Scholar 

  35. Young JM, Bennett C, Gilhooly P, Wessells H, Ramos DE . Efficacy and safety of sildenafil citrate (Viagra) in black and Hispanic American men. Urology 2002; 60 (Suppl 2B): 39–48.

    Article  Google Scholar 

  36. Higgins JPT, Thompson SG . Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663–1682.

    Article  Google Scholar 

  37. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI, Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 2002; 21: 371–387.

    Article  Google Scholar 

  38. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J . Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol 2004; 57: 683–697.

    Article  Google Scholar 

  39. Sterne JA, Egger M . Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046–1055.

    Article  CAS  Google Scholar 

  40. Martinez-Jabaloyas JM, Gil-Salom M, Villamon-Fort R, Pastor-Hernandez F, Martinez-Garcia R, Garcia-Sisamon F . Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol 2001; 40: 641–646.

    Article  CAS  Google Scholar 

  41. Jarow JP, Burnett AL, Geringer AM . Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999; 162: 722–725.

    Article  CAS  Google Scholar 

  42. Virag R . Indications and early results of sildenafil (Viagra) in erectile dysfunction. Urology 1999; 54: 1073–1077.

    Article  CAS  Google Scholar 

  43. Park K, Ku JH, Kim SW, Paick JS . Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int 2005; 95: 366–370.

    Article  Google Scholar 

  44. McMahon CG, Samali R, Johnson H . Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 2000; 164: 1192–1196.

    Article  CAS  Google Scholar 

  45. Shabsigh R . Efficacy of sildenafil citrate (Viagra) is not affected by aetiology of erectile dysfunction. Int J Clin Pract Suppl 1999; 102: 19–20.

    CAS  PubMed  Google Scholar 

  46. Stern JM, Simes RJ . Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997; 315: 640–645.

    Article  CAS  Google Scholar 

  47. Ioannidis JP . Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998; 279: 281–286.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Freiburg University Medical Center, Freiburg, Germany

    L Kriston, A Harms & M M Berner

Authors
  1. L Kriston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Harms
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M M Berner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M M Berner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kriston, L., Harms, A. & Berner, M. A meta-regression analysis of treatment effect modifiers in trials with flexible-dose oral sildenafil for erectile dysfunction in broad-spectrum populations. Int J Impot Res 18, 559–565 (2006). https://doi.org/10.1038/sj.ijir.3901479

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901479

Keywords

This article is cited by

Search

Advanced search

Quick links